Fever-tree has claimed “strong progress” in the first half of 2026, as a hot early summer powered a return to growth in the UK and momentum built abroad.
The tonic and soft drinks brand’s revenues climbed 8% to £183.6m in the half to 30 June 2026, as growth came across all regions.
In the UK, a strong off-trade performance and market share gains helped Fever-tree return to growth with 3% growth in sales to £49.5m.
Expansion in the US was significantly faster, with an 11% jump in revenues at constant currency to £66.9m, as momentum built under its partnership with Molson Coors. Fever-tree took its highest-ever market share for ginger beer and tonic in the nation.
Profits rose with sales, with EBITDA up 9% in the half to £20.1m.
“”We’ve made strong progress in the first half of the year. In the US, our partnership with Molson Coors is delivering, with sales momentum building, market share increasing, and our first national marketing campaign helping bring the brand to more consumers than ever before,” said Fever-tree CEO and co-founder Tim Warrillow.
“It’s also been encouraging to see the UK return to growth. Our new marketing campaign, Straight up or Mixed, landed at exactly the right time as consumers made the most of the summer weather, while products such as Ginger Beer and Mexican Lime Soda continue to demonstrate how the Fever-Tree brand can thrive whether consumers are choosing to drink alcohol or not.
“We have continued to trade well through the summer and are confident in delivering market expectations for the full year. Our diversification strategy is expanding the opportunity for the brand, while our increasingly cash-generative business model allows us to invest behind future growth and deliver attractive returns to shareholders.”
No comments yet